ATE276262T1 - Oxazinochinolone für die behandlung viraler infektionen - Google Patents
Oxazinochinolone für die behandlung viraler infektionenInfo
- Publication number
- ATE276262T1 ATE276262T1 AT01948231T AT01948231T ATE276262T1 AT E276262 T1 ATE276262 T1 AT E276262T1 AT 01948231 T AT01948231 T AT 01948231T AT 01948231 T AT01948231 T AT 01948231T AT E276262 T1 ATE276262 T1 AT E276262T1
- Authority
- AT
- Austria
- Prior art keywords
- oxazinoquinolones
- treatment
- viral infections
- infections
- viral
- Prior art date
Links
- 208000036142 Viral infection Diseases 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
- C07D498/20—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21755500P | 2000-07-12 | 2000-07-12 | |
| US26221101P | 2001-01-17 | 2001-01-17 | |
| US26825501P | 2001-02-13 | 2001-02-13 | |
| PCT/US2001/016507 WO2002004462A1 (en) | 2000-07-12 | 2001-06-29 | Oxazinoquinolones useful for the treatment of viral infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE276262T1 true ATE276262T1 (de) | 2004-10-15 |
Family
ID=27396428
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT01948231T ATE276262T1 (de) | 2000-07-12 | 2001-06-29 | Oxazinochinolone für die behandlung viraler infektionen |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1299395B1 (de) |
| JP (1) | JP2004502777A (de) |
| AR (1) | AR030304A1 (de) |
| AT (1) | ATE276262T1 (de) |
| AU (1) | AU2001269704A1 (de) |
| DE (1) | DE60105614T2 (de) |
| ES (1) | ES2227232T3 (de) |
| PE (1) | PE20020189A1 (de) |
| PT (1) | PT1299395E (de) |
| TR (1) | TR200402534T4 (de) |
| WO (1) | WO2002004462A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6821969B2 (en) | 2001-02-13 | 2004-11-23 | Pharmacia & Upjohn Company | Thioxazinoquinolones as antiviral agents |
| NZ543006A (en) * | 2003-04-07 | 2009-03-31 | Cylene Pharmaceuticals Inc | Substituted quinobenzoxazine analogs |
| ES2427247T3 (es) | 2006-03-13 | 2013-10-30 | Kyorin Pharmaceutical Co., Ltd. | Aminoquinolonas como inhibidores de GSK-3 |
| CN101855228B (zh) | 2007-09-11 | 2012-10-24 | 杏林制药株式会社 | 作为gsk-3抑制剂的氰基氨基喹诺酮和四唑并氨基喹诺酮 |
| CN102344457B (zh) | 2007-09-12 | 2015-07-22 | 杏林制药株式会社 | 作为 gsk-3 抑制剂的螺环状氨基喹诺酮 |
| CN102421784B (zh) | 2009-03-11 | 2015-09-30 | 杏林制药株式会社 | 作为gsk-3抑制剂的7-环烷基氨基喹诺酮 |
| KR20150070347A (ko) | 2012-10-16 | 2015-06-24 | 얀센 파마슈티카 엔.브이. | Ror-감마-t의 메틸렌 결합 퀴놀리닐 조절제 |
| HK1213250A1 (zh) | 2012-10-16 | 2016-06-30 | Janssen Pharmaceutica, N.V. | RORγT的雜芳基連接的喹啉基調節劑 |
| ES2628365T3 (es) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| AU2014334619A1 (en) | 2013-10-15 | 2016-04-21 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORyt |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| KR20160068956A (ko) | 2013-10-15 | 2016-06-15 | 얀센 파마슈티카 엔.브이. | RORyT의 퀴놀리닐 조절제 |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| EP3849979A1 (de) | 2018-09-12 | 2021-07-21 | Novartis AG | Antivirale pyridopyrazindionverbindungen |
| TW202535873A (zh) | 2019-09-26 | 2025-09-16 | 瑞士商諾華公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4959363A (en) * | 1989-06-23 | 1990-09-25 | Sterling Drug Inc. | Quinolonecarboxamide compounds, their preparation and use as antivirals. |
| US5792774A (en) * | 1996-02-21 | 1998-08-11 | Chiroscience Limited | Quinolones and their therapeutic use |
| WO1999040093A2 (en) * | 1998-02-04 | 1999-08-12 | Board Of Regents, The University Of Texas System | Synthesis of quinobenzoxazine analogues with topoisomerase ii and quadruplex interactions for use as antineoplastic agents |
| US6248739B1 (en) * | 1999-01-08 | 2001-06-19 | Pharmacia & Upjohn Company | Quinolinecarboxamides as antiviral agents |
| TW500724B (en) * | 1999-10-05 | 2002-09-01 | Pharmacia & Amp Upjohn Company | Oxazinoquinolones useful for the treatment of viral infections |
-
2001
- 2001-06-29 PT PT01948231T patent/PT1299395E/pt unknown
- 2001-06-29 TR TR2004/02534T patent/TR200402534T4/xx unknown
- 2001-06-29 JP JP2002509326A patent/JP2004502777A/ja active Pending
- 2001-06-29 ES ES01948231T patent/ES2227232T3/es not_active Expired - Lifetime
- 2001-06-29 EP EP01948231A patent/EP1299395B1/de not_active Expired - Lifetime
- 2001-06-29 WO PCT/US2001/016507 patent/WO2002004462A1/en not_active Ceased
- 2001-06-29 AU AU2001269704A patent/AU2001269704A1/en not_active Abandoned
- 2001-06-29 AT AT01948231T patent/ATE276262T1/de not_active IP Right Cessation
- 2001-06-29 DE DE60105614T patent/DE60105614T2/de not_active Expired - Fee Related
- 2001-07-09 PE PE2001000677A patent/PE20020189A1/es not_active Application Discontinuation
- 2001-07-12 AR ARP010103311A patent/AR030304A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR030304A1 (es) | 2003-08-20 |
| AU2001269704A1 (en) | 2002-01-21 |
| DE60105614T2 (de) | 2005-10-06 |
| PT1299395E (pt) | 2005-01-31 |
| TR200402534T4 (tr) | 2004-12-21 |
| WO2002004462A1 (en) | 2002-01-17 |
| ES2227232T3 (es) | 2005-04-01 |
| DE60105614D1 (de) | 2004-10-21 |
| JP2004502777A (ja) | 2004-01-29 |
| EP1299395B1 (de) | 2004-09-15 |
| PE20020189A1 (es) | 2002-03-02 |
| EP1299395A1 (de) | 2003-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60325498D1 (de) | 1-acyl-pyrrolidin-derivate für die behandlung von viralen infektionen | |
| ATE345331T1 (de) | Verbindungen verwendbar für die behandlung von entzündungskrankheiten | |
| DE60233414D1 (de) | Kombinationen für die behandlung entzündlicher erkrankungen | |
| DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
| ATE551340T1 (de) | Azabicyclisch- substituierte annelierte heteroaryl-verbinungen für die behandlung von krankheiten | |
| DE60105614D1 (de) | Oxazinochinolone für die behandlung viraler infektionen | |
| DE60124302D1 (de) | Thiazolderivate zur behandlung von ppar-lierte krankheiten | |
| ATE312117T1 (de) | Verbindungen für die behandlung von ischämie | |
| DE60239558D1 (de) | Kombinationen für die behandlung von immun-entzündlichen erkrankungen | |
| ATE457998T1 (de) | Abgeschwächte mikroorganismen für die behandlung von infektionen | |
| DE60136477D1 (de) | Retinoide zur behandlung von emphysem | |
| DE60236218D1 (de) | CCR5 Antagonisten verwendbar für die Behandlung von Aids | |
| DE60016047D1 (de) | Dihydrobenzopyrane, dihydrobenzothiopyrane und tetrahydrochinoline zur behandlung cox-2-abhängiger krankheiten | |
| ATE253578T1 (de) | Oxazinochinolone zur behandlung von viralen infektionen | |
| DE60103685D1 (de) | Behandlung von Poriomania | |
| NO20032769L (no) | Kombinasjonsmetode for behandling av virale infeksjoner | |
| PT1268482E (pt) | Piranoindois para o tratamento de glaucoma | |
| ATE391507T1 (de) | S-methyl-dihydro-ziprasidone für die behandlung von schizophrenie | |
| DE60005685D1 (de) | Oxazinocarbazole zur behandlung von cns-erkrankungen | |
| ATE277924T1 (de) | Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression | |
| FI20010472A0 (fi) | Menetelmä alfa-pineenin hydraamiseksi | |
| DE60218529D1 (de) | Isochroman verbindungen für die behandlung von cns-krankheiten | |
| ATE253556T1 (de) | Aminoacylaroylpyrrole für die behandlung des neuropathischen schmerzes | |
| DE60114448D1 (de) | Imidazolonderivate zur behandlung viraler krankheiten | |
| IS6626A (is) | Kristallskenndur meðferðarmiðill |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1299395 Country of ref document: EP |
|
| REN | Ceased due to non-payment of the annual fee |